Gloria Wasilewski

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysis”.

Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysis

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.10.071

N/A

0DataRank · unranked

6 citations

Gloria Wasilewski, Mario E. Lacouture, Christopher A. Barker, Bernice Y. Yan

A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110478

N/A

0DataRank · unranked

7 citations

Sandra P. D’Angelo, Gloria Wasilewski, Alexa Steckler, Ming Lian, Zhigang Zhang +4 more